Oncorus
Immuno-oncology company developing oncolytic viruses to fight cancer.
Market cap
$3.3m
Enterprise value
$28m
Share price
$0.12 ONCR
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor investor | €0.0 | round |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
| investor investor investor investor investor investor investor investor investor investor investor investor investor | €0.0 | round | |
| N/A | N/A | IPO | |
| Total Funding | 000k | ||
Celgene(exited)
MPM BioImpact(exited)
Deerfield(exited)
Astellas Venture(exited)
UBS(exited)
Deerfield Capital Management(exited)
Arkin Holdings(exited)
Sphera Funds Management(exited)
IMM Investment(exited)
SV Investment Partners(exited)
UTC Investment(exited)
Shinhan Investment Corp.(exited)
Shinhan Private Equity(exited)
University of Pittsburgh(exited)
Perceptive Advisors(exited)
K2 HealthVentures(exited)
BioImpact Capital(exited)
SV Investment(exited)
| USD | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.